GSGrace Ambrose Shayo

Grace Ambrose Shayo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Grace Ambrose Shayo has a total of 85 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Limited Knowledge on Asthma and Pressurized Metered-Dose Inhaler Technique Among Health Care Professionals Attending Asthmatic Patients in Dar es Salaam, Tanzania

    by Grace Ambrose Shayo, Aisha Awadh, Mwanaada Ahmed Kilima

    Introduction: Receiving wrong health education from health care professionals (HCPs) might contribute to patients' poor inhaler technique. We set out to investigate HCPs' knowledge on asthma and metered-dose inhaler technique in selected health facilities in Dar es Salaam, Tanzania. Methods: In a cross-sectional study done from August 2020 to February 2021, participant's demographics were recorded. The inhaler technique was assessed using a 12-step checklist. Participants had correct inhaler technique when all the steps were performed correctly; otherwise, the technique was poor. An 18-question questionnaire for health care professional knowledge was used to assess asthma knowledge. One point was awarded to each correctly answered question, whereas a zero point was given to a wrongly answered or unanswered question. Knowledge was adequate if the score was 13/18 or higher. Chi-square was used to compare categorical data, while analysis of variance was used for comparison of mean scores for asthma knowledge and inhaler technique. A p value ≤0.05 was considered significant. Results: A total of 114 participants were enrolled; 57% were medical officers, and 59.6% had work experience of p = 0.039) and being a medical specialist (p = 0.002). Only 4.4% of the participants did all the steps of inhaler technique correctly. Conclusion: Knowledge on asthma and inhaler use technique is generally lacking among health care professionals. In-service training on asthma and inhaler demonstration should be considered for HCPs in asthma clinics.


  • Open Access

    Seroprevalence and Determinants of SARS-Cov-2 Antibodies Among Healthcare Workers in Dar es Salaam, Tanzania

    by Erick Mboya, Claudia Hawkins, Doreen Kamori, Davis Amani, Grace Shayo, Raphael Z. Sangeda, Joan Rugemalila, Faraja Chiwanga, Sabina Mugusi, Upendo Nkwera, et al.

    Background Studies from the Sub-Saharan African (SSA) countries suggest an underestimate of SARS-CoV-2 infections early in the pandemic. To understand and inform infection control strategies to protect key and vulnerable populations, this study investigated the seroprevalence and factors associated with anti-SARS CoV-2 seropositivity among healthcare workers (HCWs) in Dar es Salaam, Tanzania. Methods This cross-sectional study was conducted in three tertiary and national hospitals in Dar es Salaam, Tanzania. Employed HCWs aged ≥18 years were enrolled between October 2021 and March 2022. Laboratory testing for Immunoglobulin G (IgG) against SARS-CoV-2 nucleocapsid (N) or spike (S) proteins was performed using WHO/FDA pre-qualified SARS-CoV-2 ELISA test kits, and data were collected on demographics and COVID-19-related exposures. Descriptive statistics were used to determine the SARS-CoV-2 antibody prevalence. Multivariable Modified Poisson regression with robust standard errors accounting for clustering within sites was used to test the independent association between HCW characteristics and SARS-CoV-2 serologic status. Results A total of 402 participants [mean age (SD) of 37.9 (9.7) years] were included in this study. 150 (37.3%) reported receiving at least one dose of SARS-CoV-2 vaccine. The overall seroprevalence of anti-SARS-CoV-2 antibodies (anti-SARS-CoV-2 IgG (S or N)) was 90.9% (358/394) among those with valid results. HCWs who reported receiving the SARS-CoV-2 vaccine were 1.14 times more likely to have anti-SARS-CoV-2 antibodies compared to those who reported not being vaccinated (aPR (95% CI) = 1.14 (1.03- 1.26)). HCWs who believed to have contracted COVID-19 previously but never tested had an 11% higher risk of being seropositive for SARS-CoV-2 IgG compared to those who thought never to have contracted COVID-19 before (aPR (95% CI) = 1.11 (1.05- 1.16)). Anesthetists and HCWs working in the laboratory and Obstetrics and Gynecology departments were more likely to have SARS-CoV-2 antibodies than HCWs from the Emergency Medicine Department (EMD). Conclusion The seroprevalence of anti-SARS-CoV-2 IgG among HCWs in this study was high in this population indicating high SARS-CoV-2 exposure among HCWs. Our work highlights the need for more effective infection control practices in healthcare settings in future pandemics like these, especially among HCWs at highest risk.

  • Open Access

    Kidney disease among adults on tenofovir-based second-line antiretroviral therapy in Dar es Salaam, Tanzania

    by Sabina F. Mugusi, Grace A. Shayo, Philip G. Sasi, Lulu S. Fundikira, Eric A. Aris, Christopher R. Sudfeld, Ferdinand M. Mugusi

    Background: Kidney disease is a growing non-AIDS-related comorbidity among people living with HIV (PLWH). Tenofovir disoproxil fumarate (TDF) can result in proximal tubulopathy and acute tubular injury, whereas atazanavir/ritonavir (ATV/r) can cause interstitial nephritis and renal stones, both of which can lead to chronic kidney disease. Objectives: To examine the relationship between second-line combination antiretroviral therapy (ART) and the risk of kidney disease and morphological changes among PLWH in Dar es Salaam, Tanzania. Method: A cross-sectional study of adult PLWH receiving TDF-based second-line ART. Socio-demographic and clinical data were gathered, and laboratory tests were conducted to determine the estimated glomerular filtration rate (eGFR). Ultrasonography was performed to visualise the kidneys. Results: A total of 323 patients were enrolled (67.8% women), with a median age of 44 (interquartile range [IQR]: 39–51) years. Patients were on second-line ART for a median of 49 [IQR: 25–73] months, and 60% received ATV/r. Low eGFR (< 90 mL/min per 1.73 m2) was found in 22% of patients, proportionately higher among patients on ATV/r compared to those on a lopinavir/ritonavir (LPV/r) (P < 0.05). Nearly one-third (32.2%) of patients had a triad of renal calcinosis, renal calculi, and nephritis on ultrasonography. Patients using ATV/r had significantly smaller kidney volumes and greater proportions of renal calculi and nephritis compared to those on LPV/r (P < 0.05). Conclusion: Adults on second-line ART containing TDF were found to have a high prevalence of renal kidney disease in the Tanzanian context. Predictors of kidney disease were older age, proteinuria, and ATV/r-based regimen as compared to LPV/r.


  • Open Access

    Elephantiasis mimicry in recurrent lower limb skin infections in a diabetic patient: a case report

    by Puneet Bramania, Emmaeli Moshi, Andrew Foi, Grace Shayo

    Chronic edema as a complication of systemic diseases or infections can mimic filarial lymphedema (also known as elephantiasis) and considered so. We describe a case of chronic lymphedema that mimicked elephantiasis in a diabetic man. The patient was a 70-year-old black man, bed-bound at the time of admission following a diagnosis of stroke and hypertension in the previous 5 years. He had been diabetic for 20 years with poorly controlled diabetes mellitus. He suffered recurrent bilateral lower limb skin infections for 5 years prior to admission that culminated into progressive lowerlimb edema. The infections eventually complicated into skin edema, hardening, fissuring, and hyperkeratotic plaques. The physical examination revealed Tinea pedis and bilateral non-pitting edema of lowerlimbs to the level of the knees. Investigations confirmed non-filarial lymphedema-related skin changes. The absence of the classic pebbly/cobblestone skin changes ruled out elephantiasis nostra verrucosa (ENV), with a possibility of it being in the early stages of evolution. The patient’s skin fissuring and infections were successfully treated with antibiotics and antifungals while compression stockings helped to relieve the edema. Chronic lymphedema can complicate repeated non-filarial infections of lower limbs. Its fissures are a risk factor for cellulitis, prompting early identification and management of both infections and lymphedema to halt their vicious cycle, especially in at risk populations like diabetics.


  • Open Access

    Patient reported experience measures on HIV viral load testing at public health facilities in Dar es Salaam, Tanzania: A convergent mixed method study

    by Peter M. Karoli, Grace A. Shayo, Elizabeth H. Shayo, Christine V. Wood, Theresia A. Ottaru, Claudia A. Hawkins, Erasto V. Mbugi, Sokoine L. Kivuyo, Sayoki G. Mfinanga, Sylvia F. Kaaya, et al.

    While viral load (VL) testing is critical to effective treatment of human immunodeficiency virus (HIV), little is known about patients’ experiences with, and barriers to VL-testing in the context of HIV infection. We assessed patient reported experience measures (PREMs) on VL-testing in public HIV clinics in Tanzania. In a cross-sectional convergent mixed method study, we collected information on VL test related PREMs, clinical and sociodemographic factors. PREMs were measured using a 5-point Likert scale. Focus Group Discussions (FGDs) explored on experience, access, and barriers to VL-testing. Descriptive statistics summarized patients’ factors and PREMs. Logistic regression was used to explore association of patient factors, PREMs and satisfaction with VL-testing services. Thematic analysis was used for qualitative data. A total of 439 (96.48%) respondents completed the survey, 331 (75.40%) were female, median (IQR) age was 41(34, 49) years. A total of 253(57.63%) had a VL test at least once in the past 12 months, of whom 242(96.0%) had VL92.0%) reported good or very good health services responsiveness (HSR). A scale of very good was chosen by the majority for being treated with respect 174(39.6%), listened to 173(39.4%), following advice 109(24.8%), being involved in decisions 101(23.0%), and for communication 102(23.3%). Satisfaction on VL-testing services was significantly associated with respondents following care providers’ advice, (aOR) = 2.07 [95%CI 1.13–3.78], involvement in decisions aOR = 4.16 [95%CI 2.26–7.66], and communication aOR = 2.27 [95%CI 1.25–4.14]. FGDs findings converged with the survey data, with identified barriers to VL test including lack of autonomy in decision making, little awareness on the benefits of the test, long waiting time, stigma, competing priorities for those with comorbidities and transport costs. Satisfaction on VL-testing was largely a result of involvement in decision making, following care provider’s advice and good communication; entities needing universal improvement across the country.


  • Open Access

    Inhaler Non-Adherence, Associated Factors and Asthma Control among Asthma Patients in a Tertiary Level Hospital in Tanzania

    by Grace A. Shayo, Amina Omary, Ferdinand Mugusi

    Background: Inhaled medications including corticosteroids are the most effective long-term controller medicines for asthma-related chronic airway inflammation. Despite this fact, 30% to 70% of the uncontrolled asthma patients report non-adherence to their inhalers. The study investigated factors affecting inhaler non-adherence among outpatient asthma patients in Muhimbili National Hospital, Dar es Salaam Tanzania and related the level of inhaler adherence to the extent of asthma control. Methods: A cross-sectional hospital-based study was conducted among patients with bronchial asthma in the pulmonology clinic of Muhimbili National Hospital in Dar-es-salaam, Tanzania. Patients’ demographic, clinical and socio-economic factors were collected using a structured questionnaire. Medication adherence was self-reported using a 10-item Test of Adherence to Inhalers (TAI) questionnaire. Adherence was gauged as good when the score was 50, intermediate (score 46-49) or poor (score ≤ 45). Asthma control was assessed using a 5-question Asthma Control Test (ACT). A score of ≥20 meant well controlled asthma while a score of ≤19 meant poorly controlled asthma. Patients’ inhaler use technique was assessed using a 12-step checklist. Patient’s technique was regarded correct when all the steps were performed correctly. Categorical data were summarised as proportions. Binary logistic regression was performed to identify factors associated with inhaler non-adherence. Significance level was set at p-value less than .05. Results: A total of 385 asthma patients were enrolled in the study. Females were 206 (53.5%), 232(60.3%) were nonadherent to medications and 283(73.5%) had poorly controlled asthma. Lack of health insurance, fear of medication side effects, being too busy, having alternative medication for asthma and incorrect inhaler technique were significantly associated with non-adherence to inhalers, all p-values <.05. Conclusion: The magnitude of inhaler non-adherence and poorly controlled asthma were very high. Promoting adherence through patients’ education on asthma and its management, emphasis on patients’ insurance coverage and setting aside time to care for ones’ self are fundamental in optimising asthma care and treatment.


  • Open Access

    Predictors of mortality among adolescents and young adults living with HIV on antiretroviral therapy in Dar es Salaam, Tanzania: a retrospective cohort study

    by Maryam A. Amour, Grace A. Shayo, Mecky M. Matee, Lameck Machumi, Angelica Rugarabamu, Eric A. Aris, Bruno F. Sunguya, Ferdinand M. Mugusi

    Introduction: Global AIDS‐related deaths have declined by only 10% among adolescents since its peak in 2003. This is disproportionately low compared to a decline of 74% among children aged 0–9 years old. We determined the magnitude of, and predictors of mortality among adolescents and young adults living with HIV on antiretroviral therapy (ART) in Dar‐es‐Salaam, Tanzania.Methods: A retrospective cohort study was conducted among adolescents (aged 10–19) and young adults (aged 20–24) living with HIV and enrolled in care and treatment centres in Dar es Salaam, Tanzania between January 2015 and December 2019. Data were analysed using STATA version 16. Cumulative hazard curves were used to estimate and illustrate 1‐year mortality. Predictors for mortality were assessed by the Fine and Gray competing risk regression model. Sub‐hazard ratios (SHR) and 95% confidence intervals (95% CI) were then reported.Results: A total of 15,874 young people living with HIV were included: 4916 (31.3%) were adolescents and 10,913 (68.7%) were young adults. A total of 3843 (77.5%) adolescents and 9517 (87.2%) young adults were female. Deaths occurred in 2.3% (114/4961) of adolescents and 1.2% (135/10,913) of young adults (p < 0.001). Over a follow‐up of 9292 person‐years, the mortality rate was 3.8 per 100 person years [95% CI 3.2–4.6/100 person‐years] among adolescents and 2.1 per 100 person‐years among young adults [95% CI 1.8–2.5/100 person‐years]. Independent predictors of mortality among adolescents were male sex (adjusted (SHR) aSHR = 1.90, 95% CI: 1.3–2.8), CD4 count < 200 cells/mm3 (aSHR = 2.7, 95% CI: 1.4–5.0) and attending a private health facility (aSHR = 1.7, 95% CI: 1.1–2.5). Predictors of mortality among young adults were CD4 count < 200 cells/mm3 (aSHR = 2.8, 95% CI 1.7–4.5), being underweight (aSHR = 2.1, 95% CI: 1.4–3.3) and using nevirapine‐based therapy (aHR = 8.3, 95% CI: 3.5–19.5).Conclusions: The mortality rate for persons living with HIV and on ART in Tanzania was significantly higher in adolescents than young adults. Age‐ and sex‐specific risk factors identify targets for intervention to reduce mortality among affected adolescents and young adults.


  • Open Access

    Clinical and Imaging Features of Adults with Recurrent Pulmonary Tuberculosis - A Prospective Case-Controlled Study

    by Tumaini J. Nagu, Monica A. Mboka, Zuhura F. Nkrumbih, Grace Shayo, Mucho M. Mizinduko, Ewaldo V. Komba, Markus Maeurer, Alimuddin Zumla, Ferdinand Mugusi


  • Open Access

    The prevalence of human immunodeficiency and of hepatitis B viral infections is not increased in patients with sickle cell disease in Tanzania

    by Grace Shayo, Irene Makundi, Lucio Luzzatto

    Background: Tanzania ranks as the fourth country in the world with respect to the number of sickle cell disease (SCD) births; it is also endemic to the human immunodeficiency virus (HIV) and the hepatitis B virus (HBV). This study was done to determine the prevalence of HIV and HBV infections among SCD patients in Dar es Salaam, Tanzania. Methods: A multicenter hospital-based descriptive cross sectional study was carried out among participants aged ≥ 16 years with a proven diagnosis of SCD. Socio-demographic and clinical data were recorded. Blood samples were drawn for HIV and HBV diagnosis. All categorical variables were summarized into frequencies. Results: There were 185/325 (56.9 %) females. The mean age (SD) was 23.0 ± 7.5 years. The prevalence of HIV was 1.8 %; the prevalence of HBV was 1.2 %. Conclusions: The prevalence of both HIV and HBV in SCD patients is no greater than in the general population of Dar es Salaam or Tanzania. For associations, a large study would be needed. From a detailed blood transfusion history of SCD patients we found no evidence that HIV or HBV infection was transmitted through blood transfusion.